[go: up one dir, main page]

MA22647A1 - PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT. - Google Patents

PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT.

Info

Publication number
MA22647A1
MA22647A1 MA22937A MA22937A MA22647A1 MA 22647 A1 MA22647 A1 MA 22647A1 MA 22937 A MA22937 A MA 22937A MA 22937 A MA22937 A MA 22937A MA 22647 A1 MA22647 A1 MA 22647A1
Authority
MA
Morocco
Prior art keywords
amide
ester
preparation
new product
new
Prior art date
Application number
MA22937A
Other languages
French (fr)
Inventor
Rahman Sk
Wordle Ka
Kennett Ga
David King Francis
Mary Gaster Laramie
Sanger Gj
Baxter Gs
Raymond Mulholland Keith
Adrian Wyman Paul
Kauman Aj
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919119692A external-priority patent/GB9119692D0/en
Priority claimed from GB929202510A external-priority patent/GB9202510D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA22647A1 publication Critical patent/MA22647A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA22937A 1991-09-14 1992-09-09 PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT. MA22647A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119692A GB9119692D0 (en) 1991-09-14 1991-09-14 Pharmaceuticals
GB929202510A GB9202510D0 (en) 1992-02-06 1992-02-06 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MA22647A1 true MA22647A1 (en) 1993-04-01

Family

ID=26299541

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22937A MA22647A1 (en) 1991-09-14 1992-09-09 PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT.

Country Status (4)

Country Link
CN (1) CN1040436C (en)
AP (1) AP373A (en)
IL (1) IL103138A (en)
MA (1) MA22647A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
US20050032866A1 (en) * 2000-08-07 2005-02-10 Bonhomme Mireille Marguerite Jeanne The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
ITMI20031468A1 (en) * 2003-07-18 2005-01-19 Acraf ATIVE DRUG IN NEUROPATHIC PAIN
CN103420989B (en) * 2012-05-15 2016-03-23 华中科技大学 Benzodioxane derivative and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2396757A2 (en) * 1977-07-08 1979-02-02 Ile De France Psycho-functional alkylene bis:oxy benzamide cpds. - useful in gastroenterology, cardiology, urology, rheumatology and gynaecology
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
SE8503055D0 (en) * 1985-06-19 1985-06-19 Astra Laekemedel Ab PIPERONYLCARBOXAMIDO DERIVATIVES
FR2593504B1 (en) * 1986-01-30 1988-12-09 Ile De France NOVEL DIHYDROBENZOFURANNE - AND CHROMANE - CARBOXAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS NEUROLEPTICS

Also Published As

Publication number Publication date
AP373A (en) 1994-12-07
CN1073173A (en) 1993-06-16
CN1040436C (en) 1998-10-28
IL103138A0 (en) 1993-02-21
IL103138A (en) 1999-05-09
AP9200422A0 (en) 1992-10-31

Similar Documents

Publication Publication Date Title
MA22819A1 (en) PROCESS FOR THE PREPARATION OF A NEW PHARMACEUTICAL PRODUCT.
MA22626A1 (en) PROCESS FOR THE PREPARATION OF IMIDAZOLYL-ALKENOIC ACIDS.
MA22668A1 (en) PROCESS FOR THE PREPARATION OF OXAMIDES.
MA22481A1 (en) PROCESS FOR THE PREPARATION OF IMIDAZOLYL - ALKENOIC ACIDS.
FR2645992B1 (en) PROCEDURE FOR SHIPPING GOODS
MA22894A1 (en) PROCESS FOR THE PREPARATION OF A VACCINE.
MA22889A1 (en) PROCESS FOR THE PREPARATION OF NEW PRODUCTS
MA22907A1 (en) NEW PROCESS FOR THE PREPARATION OF CLAVULANIC ACID.
FR2689887B1 (en) PROCESS FOR THE PREPARATION OF A BIPHENYL DERIVATIVE.
FR2707087B1 (en) New process for the preparation of ergothionein.
MA22443A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
FR2750015B1 (en) PROCESS FOR THE MANUFACTURE OF A CHEESE PRODUCT
FR2627493B1 (en) PROCESS FOR THE PREPARATION OF ISOQUINOLEIN DERIVATIVES
MA23186A1 (en) PROCESS FOR THE PREPARATION OF AZAMACROCYCLIC OR ACYCLIC ESTER AMINOPHOSPHANATE DERIVATIVES.
MA23179A1 (en) PROCESS FOR THE PREPARATION OF A CRYSTALLINE MONOHYDRATE OF A SPIROSTANYLGLYCOSIDE
MA22647A1 (en) PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT.
FR2589331B1 (en) PROCESS FOR THE PREPARATION OF A FERMENTED DAIRY PRODUCT
FR2752675B1 (en) PROCESS FOR THE PREPARATION OF A FOOD PRODUCT
FR2677354B1 (en) PROCESS FOR THE PREPARATION OF ESTERS OF RACEMISABLE ACIDS.
FR2644161B1 (en) PROCESS FOR THE PREPARATION OF N-ARYLSUBSTITUTED AMIDES
MA24309A1 (en) PROCESS FOR THE PREPARATION OF A CRYSTALLINE PHARMACEUTICAL PRODUCT.
MA22051A1 (en) PROCESS FOR OBTAINING A PHARMACEUTICAL FORMULATION
MA22200A1 (en) PROCESS FOR THE PREPARATION OF AMINODIOL DERIVATIVES
MA23081A1 (en) PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVES
MA22880A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.